Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : China entities : X financial save search
Aurealis Therapeutics and Xbiome Enter into a License and Collaboration Agreement for Aurealis Four-in-One Diabetic Foot Ulcer and Inflammatory Disease Cell and Gene Therapy AUP-16 in Greater China
Published: 2022-01-28 (Crawled : 11:00) - biospace.com/
XYF | $3.78 0.0% 5.6K
|
Finance
|
| O: 4.35%
H: 0.0%
C: -4.87%
aup-16 urea gene therapy license therapeutics disease cel one china therapy collaboration diabetic diabetes
AFFiRiS and Frontier Biotechnologies announce license agreement for AFFITOPE®AT04, an active immunotherapy targeting PCSK9 to treat hypercholesterolemia, in Greater China
Published: 2022-01-03 (Crawled : 19:00) - biospace.com/
XYF | $3.78 0.0% 5.6K
|
Finance
|
| O: 1.33%
H: 4.26%
C: 2.62%
at04 affitope license cholesterol immunotherapy china therapy biotech iot hypercholesterolemia
China Online Education Group Announces Change to Board Composition
Published: 2021-05-11 (Crawled : 11:00) - prnewswire.com
XYF | $3.78 0.0% 5.6K
|
Finance
|
| O: 3.25%
H: 8.47%
C: 3.15%
QD | $2.275 1.11% 0.0% 620K
|
Technology Services
|
| O: -3.26%
H: 9.55%
C: 7.87%
MOGU | $1.99 5.85% 0.0% 5.8K
|
Retail Trade
|
| O: -5.73%
H: 7.09%
C: 4.73%
COE | $6.47 -1.97% 0.0% 1.4K
|
Technology Services
|
| O: -1.2%
H: 5.7%
C: 2.69%
BLCT | $1.54 0.0%
|
Technology Services
|
| O: -2.92%
H: 5.75%
C: 0.9%
education china
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.